Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Natera
Fierce Pharma
Exelixis aims to be a top 5 solid tumor drugmaker in the US: CEO
With phase 3 results for a potential new blockbuster on the horizon and a growing pipeline, Exelixis' CEO laid out his aspirations for the company.
Angus Liu
Jan 16, 2026 1:00pm
Natera buys Foresight Diagnostics in $450M cancer testing deal
Dec 5, 2025 11:57am
Fierce Pharma
Roche touts Tecentriq biomarker win in bladder cancer
Aug 18, 2025 4:17pm
Guardant awarded $292M in false advertising suit against Natera
Nov 26, 2024 10:45am
Natera offers Invitae $52.5M for prenatal screening tests
Jan 22, 2024 10:27am
The highest paid medtech CEOs
Dec 12, 2022 3:00am
